| Transplant Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | |
| Transplants | 70 | 73 | 82 | 113 | 107 | 116 | 152 | 178 | 175 |
| Functioning Graft at 2 Years PostTx | 29 | 30 | 47 | 59 | 64 | 76 | 105 | 112 | 108 |
| With Maintenance Use Recorded at 2 Years PostTx | 29 | 30 | 47 | 59 | 64 | 76 | 104 | 102 | 91 |
| CyA | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.3% | 0.0% | 0.0% | 0.0% |
| Tac | 6.9% | 3.3% | 6.4% | 28.8% | 20.3% | 42.1% | 35.6% | 41.2% | 38.5% |
| Tac + MMF/MPA | 0.0% | 3.3% | 0.0% | 0.0% | 1.6% | 1.3% | 1.0% | 0.0% | 2.2% |
| Tac + OtherAntimet | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.3% | 1.0% | 2.0% | 1.1% |
| --- + Siro/Evero | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 0.0% | 1.0% | 2.0% | 0.0% |
| CyA + Siro/Evero | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% |
| Tac + Siro/Evero | 0.0% | 6.7% | 4.3% | 3.4% | 3.1% | 2.6% | 5.8% | 2.0% | 4.4% |
| --- + Steroids | 0.0% | 0.0% | 4.3% | 0.0% | 3.1% | 1.3% | 1.0% | 0.0% | 0.0% |
| CyA + Steroids | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.3% | 0.0% | 1.0% | 1.1% |
| Tac + Steroids | 79.3% | 63.3% | 53.2% | 57.6% | 50.0% | 34.2% | 36.5% | 31.4% | 40.7% |
| Tac + MMF/MPA + Steroids | 6.9% | 0.0% | 2.1% | 0.0% | 7.8% | 5.3% | 5.8% | 2.9% | 7.7% |
| Tac + OtherAntimet + Steroids | 3.4% | 3.3% | 0.0% | 1.7% | 0.0% | 1.3% | 1.9% | 1.0% | 0.0% |
| --- + Siro/Evero + Steroids | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 0.0% | 2.9% | 2.0% | 0.0% |
| Tac + Siro/Evero + Steroids | 3.4% | 16.7% | 29.8% | 8.5% | 10.9% | 7.9% | 7.7% | 13.7% | 4.4% |
| Other Regimen | 0.0% | 3.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |